Mathai Mammen - EVP, Pharm, R&D at Johnson & Johnson

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Pharm, R&D
Stock Symbol
JNJ on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mathai Mammen since 9/18/2023

Holdings reported by Mathai Mammen for Johnson & Johnson

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 41.9K $7.21M $172.00 Feb 15, 2022 Direct
Employee Stock Options (Right to Buy) 38.7K $2.81M $72.54 Feb 14, 2022 Direct Common Stock
Restricted Share Units 3.92K $613K $156.33 Feb 14, 2022 Direct Common Stock
Performance Share Units 737 $116K $157.40 Feb 15, 2022 Direct Common Stock

Transactions reported by Mathai Mammen for Johnson & Johnson

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.